Industry Briefs

The Du Pont Co. may be its own best client for its own new venture: an innovative enterprise dedicated to cleaning contaminated groundwater and soil. Allies in the endeavor are two smaller companies: Biosystems, a Chester, Pa., firm specializing in groundwater clean-up and Dallas-based Halliburton Co., an engineering consulting firm to the petroleum industry. The three will operate jointly as DuPont Biosystems, employing microbiologists, chemists, environmental engineers, and geologists—

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The Du Pont Co. may be its own best client for its own new venture: an innovative enterprise dedicated to cleaning contaminated groundwater and soil. Allies in the endeavor are two smaller companies: Biosystems, a Chester, Pa., firm specializing in groundwater clean-up and Dallas-based Halliburton Co., an engineering consulting firm to the petroleum industry. The three will operate jointly as DuPont Biosystems, employing microbiologists, chemists, environmental engineers, and geologists—and get to work right in the corporate backyard.

Earlier this year, the New Jersey Department of Environmental Protection ordered Du Pont to pay $39 million to clean up. groundwater that had been polluted by one of its New Jersey plants. The settlement has been described as the largest by one company for a single location in the United States, so Du Pont Biosystems, a consultant to the project, will be wielding a large broom.

Nearly a decade after they discovered the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies